ArticleBMC microbiology2025
Striking mycotoxin tolerance and zearalenone elimination capacity of the decaying wood associated yeast Sugiyamaella novakii (Trichomonascaceae).
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Isolation and characterization of a novel strain of Rhizopus arrhizus for effective biodegradation and detoxification of zearalenone.World journal of microbiology & biotechnology · 2026Article
- Article
- Transcriptome changes of fission yeast cells exposed to fumonisin B1 or co-cultured with Fusarium verticillioides.Applied microbiology and biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMycotoxin-producing fungal species and their mycotoxins pose a global threat for crop production and for human and animal health. Given the increasing demand for healthier food and feed, alternative non-pesticide approaches for reducing fungal infections in crops and eliminating mycotoxin contamination in feedstock are becoming more prevalent. For such purposes, yeast species can be good candidates. Thus, the present study examined the mycotoxin tolerance and mycotoxin elimination ability of several yeast strains belonging to the Trichomonascaceae family.
resultsWhile none of the tested yeasts inhibited the growth of different Fusarium species, several yeast strains exhibited tolerance to Fusarium mycotoxins such as deoxynivalenol, zearalenone, T-2 toxin, and fumonisin B1. Sugiyamaella novakii strains displayed exceptional tolerance for the tested mycotoxins. Besides, phylogenetic analyses suggested that tolerant species clustered more closely to each other than to the sensitive species. Although whole genome sequencing of S. novakii NCAIM Y.00986 revealed several enzyme-coding genes that may have a role in mycotoxin elimination, significant mycotoxin elimination was not achieved in the case of deoxynivalenol, T-2 toxin, and fumonisin B1. However, S. novakii successfully eliminated zearalenone, likely due to cell wall adsorption rather than enzymatic degradation.
conclusionsThis study highlights the potential of S. novakii for zearalenone detoxification and emphasizes the role of yeast cell walls in mycotoxin mitigation strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.